79 related articles for article (PubMed ID: 15373771)
1. Identification of monoclonal anti-HMW-MAA antibody linear peptide epitope by proteomic database mining.
Mittelman A; Tiwari R; Lucchese G; Willers J; Dummer R; Kanduc D
J Invest Dermatol; 2004 Oct; 123(4):670-5. PubMed ID: 15373771
[TBL] [Abstract][Full Text] [Related]
2. Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
Murray JL; Gillogly M; Kawano K; Efferson CL; Lee JE; Ross M; Wang X; Ferrone S; Ioannides CG
Cancer Res; 2004 Aug; 64(15):5481-8. PubMed ID: 15289358
[TBL] [Abstract][Full Text] [Related]
3. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactivity of mimotopes with a monoclonal antibody against the high molecular weight melanoma-associated antigen (HMW-MAA) does not predict cross-reactive immunogenicity.
Hafner C; Wagner S; Allwardt D; Riemer AB; Scheiner O; Pehamberger H; Breiteneder H
Melanoma Res; 2005 Apr; 15(2):111-7. PubMed ID: 15846144
[TBL] [Abstract][Full Text] [Related]
5. Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysis.
Willers J; Lucchese A; Mittelman A; Dummer R; Kanduc D
Exp Dermatol; 2005 Jul; 14(7):543-50. PubMed ID: 15946243
[TBL] [Abstract][Full Text] [Related]
6. High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells.
Riemer AB; Hantusch B; Sponer B; Kraml G; Hafner C; Zielinski CC; Scheiner O; Pehamberger H; Jensen-Jarolim E
Cancer Immunol Immunother; 2005 Jul; 54(7):677-84. PubMed ID: 15565329
[TBL] [Abstract][Full Text] [Related]
7. Computational peptide dissection of Melan-a/MART-1 oncoprotein antigenicity.
Tiwari R; Geliebter J; Lucchese A; Mittelman A; Kanduc D
Peptides; 2004 Nov; 25(11):1865-71. PubMed ID: 15501517
[TBL] [Abstract][Full Text] [Related]
8. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
[TBL] [Abstract][Full Text] [Related]
9. Non-self-discrimination as a driving concept in the identification of an immunodominant HMW-MAA epitopic peptide sequence by autoantibodies from melanoma cancer patients.
Dummer R; Mittelman A; Fanizzi FP; Lucchese G; Willers J; Kanduc D
Int J Cancer; 2004 Sep; 111(5):720-6. PubMed ID: 15252841
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants.
Giacomini P; Natali P; Ferrone S
J Immunol; 1985 Jul; 135(1):696-702. PubMed ID: 2582052
[TBL] [Abstract][Full Text] [Related]
11. Idiotypic cascade in the human high molecular weight melanoma-associated antigen system: fine specificity and idiotypic profile of anti-anti-idiotypic monoclonal antibodies.
Yang H; Chen ZJ; Kageshita T; Yamada M; Ferrone S
Eur J Immunol; 1993 Jul; 23(7):1671-7. PubMed ID: 7686858
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometric mapping of protein epitope structures of myocardial infarct markers myoglobin and troponin T.
Macht M; Fiedler W; Kürzinger K; Przybylski M
Biochemistry; 1996 Dec; 35(49):15633-9. PubMed ID: 8961925
[TBL] [Abstract][Full Text] [Related]
13. Effect of variations in peptide sequence on anti-human milk fat globule membrane antibody reactions.
Xing PX; Reynolds K; Pietersz GA; McKenzie IF
Immunology; 1991 Feb; 72(2):304-11. PubMed ID: 1707852
[TBL] [Abstract][Full Text] [Related]
14. Human high molecular weight-melanoma associated antigen mimicry by an anti-idiotypic antibody: characterization of the immunogenicity and the immune response to the mouse monoclonal antibody IMel-1.
Chattopadhyay P; Kaveri SV; Byars N; Starkey J; Ferrone S; Raychaudhuri S
Cancer Res; 1991 Nov; 51(22):6045-51. PubMed ID: 1933867
[TBL] [Abstract][Full Text] [Related]
15. The anti-MUC1 monoclonal antibody BCP8 can be used to isolate and identify putative major histocompatibility complex class I associated amino acid sequences.
Agrawal B; Reddish MA; Christian B; VanHeele A; Tang L; Koganty RR; Longenecker BM
Cancer Res; 1998 Nov; 58(22):5151-6. PubMed ID: 9823326
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions.
Stephen CW; Helminen P; Lane DP
J Mol Biol; 1995 Apr; 248(1):58-78. PubMed ID: 7537340
[TBL] [Abstract][Full Text] [Related]
17. Limited diversity of human scFv fragments isolated by panning a synthetic phage-display scFv library with cultured human melanoma cells.
Noronha EJ; Wang X; Desai SA; Kageshita T; Ferrone S
J Immunol; 1998 Sep; 161(6):2968-76. PubMed ID: 9743360
[TBL] [Abstract][Full Text] [Related]
18. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles.
Kawakami Y; Robbins PF; Wang X; Tupesis JP; Parkhurst MR; Kang X; Sakaguchi K; Appella E; Rosenberg SA
J Immunol; 1998 Dec; 161(12):6985-92. PubMed ID: 9862734
[TBL] [Abstract][Full Text] [Related]
19. A mutant chaperone converts a wild-type protein into a tumor-specific antigen.
Schietinger A; Philip M; Yoshida BA; Azadi P; Liu H; Meredith SC; Schreiber H
Science; 2006 Oct; 314(5797):304-8. PubMed ID: 17038624
[TBL] [Abstract][Full Text] [Related]
20. Human high-molecular-weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody TK7-371.
Chen ZJ; Yang H; Kageshita T; Ferrone S
Cancer Res; 1991 Sep; 51(18):4790-7. PubMed ID: 1716513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
